by Rawamino | Nov 2, 2025 | Peptides
Introduction Intervertebral disc degeneration (IVDD) is characterized in experimental settings by extracellular matrix (ECM) erosion, increased catabolic enzyme activity, and persistent inflammatory signaling within the nucleus pulposus (NP). Alongside these...
by Rawamino | Nov 2, 2025 | Peptides
Introduction Skeletal tissue undergoes continual remodeling through tightly coupled formation and resorption. This balance is maintained by osteoblasts that deposit extracellular matrix and osteoclasts that dissolve mineralized tissue. Perturbations to this...
by Rawamino | Nov 1, 2025 | Peptides
Introduction Aging biology features coordinated changes in energy metabolism, genome maintenance, proteostasis, and stress signaling. At the nexus of these systems is nicotinamide adenine dinucleotide (NAD+), a ubiquitous redox cofactor and enzymatic substrate. NAD+...
by Rawamino | Nov 1, 2025 | Peptides
Introduction Aberrant redox signaling has long been implicated in experimental models of neurodegeneration, where excessive reactive oxygen and nitrogen species disturb proteostasis, mitochondrial function, and kinase networks. Within this context, the non-receptor...
by Rawamino | Oct 31, 2025 | Peptides
Introduction Neurodegenerative disorders such as Alzheimer’s disease (AD) are characterized by progressive neuronal loss and sustained neuroinflammation, a process in which glial activation contributes to synaptic dysfunction and neuronal decline. In experimental...
by Rawamino | Oct 31, 2025 | Peptides
Introduction Dopaminergic neuron loss within the nigrostriatal system is a defining feature of Parkinsonian neurodegeneration in laboratory models. Converging evidence indicates that programmed cell death (apoptosis) and chronic glial activation cooperate to erode...
